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PATTERNS OF BLOOD PRODUCT ORDERING AND UTILIZATION FOR 
SURGICAL PEDIATRIC PATIENTS SCHEDULE FOR INTRAOPERATIVE 
CELL SALVAGE 
QIUDONG CHEN 
ABSTRACT 
 Red blood cells are a scarce resource whose demand often exceeds its supply. 
Intraoperative red cell salvage has proven to be a highly effective blood conservation 
strategy, as it can reduce the need for allogeneic blood transfusion. However, the use of 
cell saver alone is not sufficient. Without specific blood ordering guidelines, the amount 
of allogeneic blood product requested and cross-matched is often much greater than the 
real level of consumption. Efficient blood ordering guidelines have been developed in the 
past, and have succeeded in providing a more accurate prediction of actual need for 
intraoperative blood transfusion and minimizing waste.  Few studies attempted to 
examine the blood ordering and utilization pattern with an emphasis on surgical cases 
that involve the use of intraoperative cell salvage. With the use of intraoperative cell-
salvage devices to reduce the amount of blood bank products required during surgery, 
considerable change in the practice of ordering cross-matched blood should be made. We 
retrospectively assessed the effectiveness of one Standardized Clinical Assessment and 
Management Plan (SCAMP) in improving the efficiency of blood utilization and 
reducing waste. This SCAMP was introduced at our Boston Children’s Hospital in July 
2012 as a blood ordering guideline for all pediatric orthopedic patients who are scheduled 
for intraoperative cell salvage. We retrospectively compared demographic variables, 
  v
clinical characteristics, and blood utilization patterns of patients who underwent 
orthopedic procedure and received cell saver blood during the 17 months prior to the 
introduction of SCAMP (n = 455) and those who underwent similar procedures during 
the 15 months after the introduction of SCAMP (n = 487). Results suggested that 
demographic variables including age, weight, and sex were similar between the pre-
SCAMP and post-SCAMP groups. It also demonstrated that after the introduction of 
SCAMP, the mean percentage utilization of blood (number of units used/number of units 
ordered x 100%) increased by 24.4% (p < 0.001), while the difference between the 
number of units ordered and number of units used reduced by 0.5 units (p < 0.001). In 
conclusion, the introduction of a SCAMP for blood product ordering has led to an 
increase in the efficiency of blood utilization and a reduction in blood waste. However, 
further evaluation and modification of the SCAMP need to be made in order to better 
predict actual level of utilization of blood products. 
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INTRODUCTION 
 
Red Blood Cells and Gas Exchange 
 Red blood cells (RBCs) in humans play an important role in the transportation of 
oxygen to various body tissues via the circulatory system. After entering the lung, oxygen 
first diffuses, in the gas phase, to reach the alveoli-capillary barrier, from an area of 
higher partial pressure to that of lower partial pressure. Next, diffusion of oxygen takes 
place in the liquid phase, down its concentration gradient across the alveoli-capillary 
barrier within the respiratory bronchioles and alveoli, into pulmonary capillaries. These 
capillaries carry deoxygenated blood from the pulmonary artery, and are extremely thin 
to minimize the distance of diffusion. Once inside the bloodstream, the majority of the 
oxygen is chemically combined with hemoglobin in RBCs, while a small amount is 
physically dissolved in plasma. The binding of oxygen to hemoglobin in RBCs helps 
unload carbon dioxide in the lung. This is due to the fact that oxygenated hemoglobin is 
more acidic in comparison with deoxygenated hemoglobin. It readily gives up its 
hydrogen ions, which combine with bicarbonate ions and shifts the chemical equilibrium 
towards the direction that favors carbon dioxide production. This way, oxygen is picked 
up by the blood in the lung, while carbon dioxide is expelled from the blood into the 
lung, and ultimately exhaled during expiration.  
The now oxygenated blood returns to the heart via the pulmonary vein, and is 
eventually pumped out of the left side of the heart into the systemic circulation to reach 
various body tissues and organs. The lowered partial pressure of oxygen at the tissue 
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capillaries reduces the percentage saturation of hemoglobin in RBCs, thereby unloading 
oxygen into the tissues where they are used for cellular respiration. At the tissue level, 
deoxygenated hemoglobin in RBCs can pick up hydrogen ions produced from the 
dissociation of carbonic acid, shifting the reaction of carbon dioxide and water towards 
the right to facilitate greater uptake of carbon dioxide from the tissue into the RBCs. 
Additionally, deoxygenated hemoglobin can chemically combine with carbon dioxide to 
form carbamino-hemoglobin, further increasing the uptake of carbon dioxide from the 
tissues. Therefore, at the tissue level, oxygen is unloaded from RBCs into the tissue, 
where carbon dioxide is taken from the tissues into the RBCs, and ultimately carried to 
the lung.  
 
Allogeneic Blood Transfusion 
It’s commonly known that RBCs are a valuable yet scarce resource, with demand 
often exceeding its supply. As a result, it is of vital importance to optimize its use. In the 
United States, approximately 14 million units of RBCs are transfused each year in order 
to provide treatment for both acute and chronic anemia (Long et al., 2012). Allogeneic 
blood transfusion, in which a patient is transfused with blood donated by another 
individual, has become the standard treatment for potentially detrimental level of 
intraoperative as well as postoperative hemoglobin caused by the large amount of blood 
loss during surgery. However, allogeneic blood transfusion is often associated with 
various risks and complications, and may therefore be undesirable. These risks and 
complication are often inherent, regardless of one’s efforts to avoid them (Kleinert, 
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Theusinger, Nuernberg, & Werner, 2010). Well-known risks include the transmission of 
various infections, hemolytic transfusion reactions, transfusion febrile reaction (Dodd, 
1992), as well as transfusion-related acute lung injury (Kopko, Marshall, MacKenzie, 
Holland, & Popovsky, 2002). Transfusion-included immunomodulation, which refers to 
allogeneic blood transfusion related immunosuppression, is also a reasonable concern. 
This may result in increased risk of tumor recurrences (Blumberg & Heal, 1994), as well 
as an increased incidence of postoperative infections (Duffy & Neal, 1996). Among the 
critically ill, past studies have also indicated that patients who receive allogeneic blood 
transfusions may be more likely to require prolonged mechanical respiratory support, 
suffer from multiple-organ dysfunction, and ultimately have an increased rate of 
mortality (Marik & Corwin, 2008). 
Because of the risks and complications mentioned above, efforts have been made 
to reduce the amount of allogeneic blood transfusion. The scarcity and cost of RBCs are 
also part of the consideration. Blood products can only come from donors, as it clearly 
cannot be manufactured. According to the estimated figured provided by the American 
Red Cross, of the 38% of the U.S. population who are eligible to donate blood, less than 
10% actually do so each year (“Blood Facts and Statistics,” n.d.). Meanwhile, the demand 
continues to grow each year, as the general population continues to age and age-related 
diseases becomes more prevalent (Bagot, Bove, Masser, & White, 2013). In terms of 
cost, the shrinking donor availability, as well as the application of laboratory tests and 
post-donation processing to minimize the risk of transfusion, continue to drive up the cost 
of allogeneic blood products.  The cost for a single unit of packed red blood cells have 
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been reported to be anywhere between $270 and $780, depending on the costs for 
storage, as well as precautionary tests and processing to ensure minimal transfusion risk 
(Shander, Hofmann, Gombotz, Theusinger, & Spahn, 2007).  
 
Intraoperative Cell Salvage: Overview 
In light of the scarcity and cost of RBCs, as well as the associated risks and 
complications, the use of intraoperative cell salvage becomes an extremely attractive and 
effective blood conservation strategy. It is used for many surgical procedures where 
medium to high volume blood loss occurs, given that the blood is not contaminated with 
undesirable substances. The standard setup of a cell salvage unit is shown in Figure 1 
(Ashworth & Klein, 2010). In general, cell salvage is the process in which blood lost 
during the surgery is collected from the operative field, washed, concentrated, filtered, 
and ultimately re-administered to the patient. More specifically, blood is first suctioned 
from the operative field during surgery. A large bored suction tip (minimum 4mm) 
should be used, and one should attempt to avoid surface skimming, which is the 
aspiration of blood mixed with large amount of room air. This is because air entrainment 
may lead to formation of bubbles that can result in cellular destruction (Liumbruno, 
Liumbruno, & Rafanelli, 2011). Together, these measures can help minimize damage to 
RBCs and increase yield and quality of collected blood. Additionally, when a blood 
moves in contact with a solid surface, shear forces occur and may cause damage to 
RBCs. Therefore, in order to prevent shear-induced hemolysis, it is recommended that 
the vacuum pressure be set as low as practical. Typically a value anywhere between 
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100mmHg and 150 mmHg is used. At times, the suction vacuum pressure can be 
increased temporarily, especially when there is a large amount of blood loss, and then 
returned to lower values later on. One study in the past demonstrated that when 
necessary, the vacuum pressure can be increased to as high as 300 mmHg without 
causing excessive hemolysis (Gregoretti, 1996).  
It is important to use a double lumen suction tubing: one lumen holds the 
suctioned blood, while the other allows the addition of anticoagulant to salvaged blood in 
order to prevent clot formation (Ashworth & Klein, 2010). Blood clots are undesirable 
because they will not only render the recovered blood useless, but also potentially 
obstruct blood flow through the entire cell saver system. Either heparin or citrate can be 
used as anticoagulant in the process of cell salvaging. There have been controversies as to 
which one is the best (Oller et al., 1976), although heparin is often preferred due to its 
ready availability and low cost. Attention should be paid in particular to the amount of 
anticoagulant added to the salvaged blood. Typically it is recommended that the ratio of 
the volume of anticoagulant solution to salvaged blood be 1:5 if heparin is used, and 1:7 
if citrate is used instead (Kuppurao & Wee, 2010). With this being said, over 
administration of heparin is usually of no serious consequence during the process of cell 
salvaging, due to the fact that all but a trace amount of heparin will be removed during 
the process of washing (Waters, 2013). 
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Figure 1. Standard set up of a cell salvage circuit. (Figure taken from Ashworth & 
Klein, 2010) 
 
The anticoagulated blood is next collected in a large reservoir, and filtered in 
order to remove large clots or debris. The remaining volume is pumped into the 
processor, which is essentially a centrifuge bowl. The structure of the bowl is depicted in 
Figure 2 (Waters, 2013). Shed blood enters the bowl through a central straw, which runs 
through a spacer that occupies the middle of the bowl, and exits at the bottom. Because 
RBCs are denser and heavier than other components of the blood, the force supplied by 
the centrifuge will push them towards the outer walls of the bowl once they passed the 
central straw. In comparison, the other less dense components such as plasma tend to 
sediment closer towards the center of the bowl, and thereby passing though the central 
straw easily and exit at the bottom into a waste bag. It is important to beware that the 
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pumping force may exceed the centrifugal force when the pumping speed is set to high 
values, resulting in poor separation of RBCs from other blood components and spillage of 
RBCs into waste product. Therefore, extra attention must be paid to ensure that RBCs are 
not being lost in the event of massive blood loss when a higher than usual pumping speed 
is chosen. The pumping of shed blood into the bowl stops when packed RBCs nearly fill 
the bowl. 
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Figure 2. Structure of a processing bowl in cell savers. Shed, anticoagulated blood 
enters the bowl via the inlet, pass through the central straw that runs through the middle 
of the bowl, and exit at the bottom. The grey centerpiece through which the central straw 
runs simply acts as a spacer and does not contain any blood. Rather, blood runs outside 
the spacer. At the bottom of the central straw, centrifugal force pushes the heavier RBCs 
towards the surface of the bowl. In contrast, lighter components of blood such as plasma 
sediments closer towards the middle and leave the bowl as waste. The red arrows 
demonstrate direction of the blood flow, and the yellow arrows shows the mechanical 
forces that are applied to the fluid as it enters the bowl. (Figure taken from Waters, 2013) 
  
 The concentration of RBCs using centrifugal force can remove approximately 70-
90% of the contaminants in shed blood. However, some contaminants remain in the 
blood and need to be further removed by the process of washing. This is done by 
pumping a wash solution into the bowl. Typically, normal saline (0.9% saline solution) is 
used as the wash solution of choice. However, one past study concluded that Isolyte S, a 
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physiologic multi-electrolyte solution, is the better choice to wash cell saver salvaged 
blood, on the basis that the use of Isolyte S resulted in fewer electrolyte or acid and base 
derangements (Halpern, Alicea, Seabrook, Spungen, & Greenstein, 1997). The process of 
washing takes approximately 5 – 10 minutes to complete, and usually produces a blood 
suspension with a hematocrit of 50-80% (Gregory & Andropoulos, 2012). After washing 
is completed, all waste products collected, including white blood cells, plasma, platelets, 
clotting factors, anticoagulant, and free plasma hemoglobin are discarded as clinical 
waste. The washed blood is next collected into a reinfusion bag. Many factors can 
influence the quality of collected blood. These include the quality of shed blood, the type 
of surgical procedure, the amount of wash solution used, as well as the degree of 
concentration achieved during separation (Kuppurao & Wee, 2010).  
The salvages RBCs can be given back to the patient either immediately or within 
4 hours after process if stored in room temperature. Currently, the maximal accepted 
storage time of salvaged RBCs is 6 hours (Allam, Cox, & Yentis, 2008). However, it is 
worthy to note that in a prospective study carried out in 1995 of 101 pediatric patients 
who underwent cardiopulmonary bypass, it was demonstrated that salvaged blood can be 
stored at room temperature for up to 18 hours with minimal chemical deterioration and 
limited microbiologic contamination (Hishon, Ryan, Lithgow, & Butt, 1995). During 
reinfusion of salvaged blood, if citrate is used as the anticoagulant, citrate toxicity may 
become a reasonable concern.  Normally, liver metabolism is rapid and this makes citrate 
toxicity very unlikely to occur. But in patients with compromised liver function, it is 
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important to give small doses of calcium in order to provide immediate and nontoxic 
reversal (Waters, 2013). 
 
Intraoperative Cell Salvage: Benefits 
The use of perioperative cell salvage possesses many benefits. With the ability to 
deliver between 50%-85% hematocrit and to remove nearly all traces of free hemoglobin 
and potassium, intraoperative cell salvage is often the standard of care in many elective 
surgical procedures. It can help reduce or avoid allogeneic transfusions altogether, 
thereby minimizing the associated risks and complications. According to a meta-analysis 
carried out in 2006 of studies that examined the use of cell salvage to minimize 
allogeneic blood transfusion published prior to 2003, it was discovered that intraoperative 
cell salvage could reduce the exposure to allogeneic blood transfusion in adult patients by 
up to 40%. This translates to an average saving of 0.67 units of allogeneic blood per 
patient without causing any adverse impact on clinical outcomes (Carless et al., 2006). 
Similarly, in pediatric surgeries, intraoperative cell salvage has also shown to reduce the 
need for allogeneic blood transfusion in procedures such as craniofacial surgery 
(Krajewski et al., 2008), elective cardiac surgery (Golab, Scohy, de Jong, Takkenberg, & 
Bogers, 2008), and spinal fusion surgery (Bowen, Gardner, Scaduto, Eagan, & 
Beckstead, 2010). Additionally, perioperative cell salvage can effectively limit blood loss 
during surgery without carrying any side-effects that may be associated with the use of 
hemostatic agents such as lysine analogous, coagulation factor concentrates, or 
antifibrinolytic agents (Kuppurao & Wee, 2010). Furthermore, it reduces the risk of 
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human error that may lead to the wrong unit of blood being given during a transfusion. 
The fact that intraoperative cell salvage requires no preoperative preparation on the part 
of the patient also makes it ideal for unexpected massive hemorrhage during surgery. 
Finally, from an economical standpoint, the use of intraoperative cell salvage has shown 
to be both cost-saving and cost-effective, especially when used in combination with 
allogeneic blood transfusion (Samnaliev et al., 2013). 
Compared with allogeneic blood, salvaged blood has shown increased mean 
erythrocyte viability as high as 88%. This is well above the minimum erythrocyte 
viability of 70% in cross-matched allogeneic blood or pre-donated autologous blood – a 
standard of the American Association of Blood Banks (Colwell, Beutler, West, 
Hardwick, & Morris, 2002). Past studies have also demonstrated normal or increased 
adenosine triphosphate (ATP) and 2,3-disphosphoglycerate (2,3-DPG) content in 
salvaged blood (Muñoz Gómez et al., 1999). Salvaged RBCs can better maintain their 
biconcave disc shape than allogeneic blood that has been stored for long periods of time. 
A 1999 study examining the changes in RBC aggregability and shape during long periods 
of storage showed that after 2 weeks of storage, the structural changes in RBCs took 
place and led to a continuous increase in their agreeability. More specifically, structure of 
RBCs changed from the normal biconcave disc to echinocytes, and this may impair the 
ability of RBCs to cross capillary beds (Hovav, Yedgar, Manny, & Barshtein, 1999). 
Therefore, given the above reasons, salvaged blood possesses better oxygen-carrying 
capacity and can delivery oxygen to body tissues more efficiently in comparison with 
allogeneic blood. Additionally, the use of salvaged blood instead of allogeneic blood 
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often resulted in an increased rate of survival after some surgical procedures, as well as 
reduced incidence of post-operative infections. According to Takemura et. al, substituting 
allogeneic blood with autologous salvaged blood for patients undergoing radical 
oesophagectomy for cancer favorably affected the survival of patients (Takemura et al., 
2005). Another randomized controlled trial of 70 patients who underwent unilateral total 
knee replacement demonstrated that when autologous salvaged blood is used rather than 
allogeneic blood, the incidence of post-operative infections is significantly less and the 
mean length of hospital stay is also reduced (Newman, Bowers, & Murphy, 1997). 
Gharehbaghian et al. proposed that the reduced incidence of post-operative infections 
associated with the use of autologous salvaged blood may be due to its effect on natural 
killer cell precursor frequency as well as levels of interferon gamma. Normally, 
immunosuppression, as a result of invasive surgery and blood loss, cause a decrease in 
natural killer cell precursor frequency and level of interferon gamma. Gharehbaghian et 
al. discovered that autologous salvaged blood could reverse this effect. Therefore this 
suggests that autologous salvaged blood contain immunostimulants (Gharehbaghian et 
al., 2004). 
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Intraoperative Cell Salvage: Disadvantages and Complications 
Despite it’s relative safety and numerous advantages, the use of intraoperative cell 
salvage as a blood conservation strategy is not completely without complications. Air 
embolism is one of the major complications that may result from intraoperative cell 
salvage (Ashworth & Klein, 2010). When blood is initially suctioned from the operative 
field and pumped into the processing bowl of a cell saver, air in the system is forced into 
the waste bag. Once processing is completed and the blood is pumped into the primary 
reinfusion bag, some of the air in the waste bag may follow the movement of blood. Over 
time, this leads to the build up of air in the primary reinfusion bag, putting the patient at 
risk of air embolism if this blood is re-administered directly. Thus, it is vital that salvaged 
blood should never be given back to the patient directly from the primary reinfusion bag. 
Instead, it should always be transferred to a secondary bag before reinfusion (Waters, 
2013). This way, as blood moves out of the primary bag into the secondary one, air is 
“burped” out of the secondary bag back into the primary one. Therefore, air embolism, 
although dangerous, is completely preventable. Figure 3 depicted the set up of primary and 
secondary reinfusion bags (Waters, 2013). 
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Figure 3. Processing steps of cell salvage. As processed, salvaged blood is pumped into 
the primary reinfusion bag, air from the waste bag may follow. Over time, build up of air 
may become significant in primary reinfusion bag. Therefore, one should never give 
blood in primary reinfusion bag back to the patient directly. In order to avoid air 
embolism, processed, salvaged blood should be transferred to a secondary bag before 
reinfusion. The arrows indicate the direction of blood flow. (Figure taken from Waters, 
2013). 
 
 Coagulopathy, the impaired ability of blood to clot, is another major issue that 
may be associated with the use of intraoperative cell salvage. Salvaged blood essentially 
contains only RBCs suspended in normal saline, since platelets and any coagulation 
factors are removed during the washing process (Ashworth & Klein, 2010). This becomes 
problematic when large volume of salvaged blood is re-infused as a result of massive 
hemorrhage during surgery, as the coagulation factors and platelets in the body are being 
diluted in essence. It has been suggested that a coagulopathy should be expected after 
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more than 2 liters of blood loss, and that under these conditions, appropriate allogeneic 
blood components, such as platelets, fresh-frozen plasma, and cryoprecipitate, should be 
given to ensure sufficient coagulation. It has been recommended that the anesthesiologist 
should also repeat full blood count, prothrombin time, activated partial thromboplastin 
time, and fibrinogen levels after the reinfusion of each liter of salvaged blood, in order to 
detect coagulopathy and to provide appropriate treatment in time (Waters, 2013). 
Additionally, disseminated intravascular coagulopathy and/or increased vascular 
permeability have been observed on occasion in patients following the infusion of 
washed salvaged blood (Bull & Bull, 1990). Increased vascular permeability may further 
lead to respiratory distress syndrome or extreme generalized edema (Heath & 
McFadzean, 1995). This has been labeled the “the salvaged blood syndrome”, and is 
thought to be related to the dilution of salvaged blood from large quantities of saline 
solution, which creates deposits of platelets and leukocytes when used with the fixed 
volume bowl system. It has been hypothesized by some that the mechanical deposition on 
the centrifuge bowl wall during the cell saving process causes activation of platelets and 
the release of leukoattractant substances, ultimately leading to increased vascular 
permeability and disseminated intravascular coagulation (DIC) (Bull & Bull, 1990).  
However, others have proposed that DIC and increased vascular permeability in patients 
who received salvaged blood is the result of a complex interaction of shock, hypothermia, 
reperfusion injury and multiple transfusions, rather than the autotransfusor itself (Tawes 
& Duvall, 1996). Therefore, it remains unclear whether the salvaged blood syndrome is a 
myth or reality. 
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Other disadvantages of the use of intraoperative cell salvage include 
contamination risks as well as hemolysis. Incomplete removal of contaminants from the 
salvaged blood may cause unwanted complications. For example, blood salvaged during 
the removal of pheochromocytomas has been shown to cause hypertension in patients 
after reinfusion (Smith, Mihm, & Mefford, 1983), because the extensive washing did not 
result in the complete removal of epinephrine and norepinephrine. Similarly, during ear, 
nose, and throat surgery, a nasal spray, oxymetazoline, is sometimes used. This substance 
may remain in salvaged blood in high concentrations even after washing, and is likely to 
cause hypertension and tachycardia upon re-administration (Waters, 2013). Hemolysis of 
RBCs may be caused by sheer stress or skimming during suction. This can be avoided by 
diluting blood with normal saline and using low vacuum pressure while suctioning 
(Waters, Williams, Yazer, & Kameneva, 2007). 
Overall, regardless of its associated complications, salvaged autologous blood is 
still relatively safe for the patient to receive. The Cleveland Clinic carried out a 5 year 
retrospective review that examined the adverse events associated with allogeneic blood 
transfusion and salvaged blood transfusion. It was discovered that incidence of adverse 
reactions with auto-transfusion was only 0.027%, in comparison with that of 0.14% with 
allogeneic blood transfusion. Additionally, the total reported adverse reactions associated 
with salvaged blood transfusion composed only 2.1% of all transfusion reactions 
investigated in the hospital during the 5-year period (Domen, 1998). 
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Intraoperative Cell Salvage: General Indications and Contraindications 
 Past recommendations from the America Association of Blood Banks (AABB) 
suggest that cell salvage is indicated when one or more of the following conditions is 
met: the patient’s anticipated blood loss is greater than 20% of his or her estimated blood 
volume; crossmatch-compatible blood is unavailable or unobtainable; the patient is 
unwilling to receive allogeneic blood transfusion, but will give consent to receive 
salvaged blood from surgery; more than 10% of patients undergoing the procedure 
require transfusion; the mean transfusion for the procedure should exceed 1 unit 
(American Association of Blood Banks Autologous Transfusion Committee, 1997). 
 It is worthy to note that the above recommendations were developed from 
comparing the cost of allogeneic blood to that of blood salvage. Since the development of 
these recommendations, the cost of allogeneic blood transfusion has increased, thereby 
changing the economic relationship from which the above recommendations were 
derived. Additionally, the expenses associated with cell salvage are much better 
understood now than before. Therefore, the above recommendations need not to be 
strictly followed. In fact, intraoperative cell salvage should still be considered even 
though only a small amount of anticipated blood loss is expected (Esper & Waters, 2011). 
 The use of intraoperative cell salvage might be indicated in numerous types of 
invasive surgical procedures according to Table 1 (Waters, 2013), especially those that 
are likely to result in large amount of blood loss, such as cardiac and orthopedic 
procedures. Overall, the decision to implement the use of cell salvage should always be 
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appropriately communicated between the case-specific surgeon and the anesthesiologist 
(Waters, 2013). It is also important to note that since the patients starting hematocrit, sex, 
age, and body weight can all influence the risk of receiving blood products (Scott, Seifert, 
Glass, & Grimson, 2003), the decision to provide cell salvage should be individualized in 
many cases. 
 
Table 1: General indications for intraoperative cell salvage (Table taken from Waters, 
2013) 
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 In terms of general contraindications, Table 2 (Esper & Waters, 2011) provides an 
extensive list. However, one must beware that most contraindications are considered 
relative rather than definitive. That is to say that there exist little experimental data to 
support the adverse effect that may be caused by the contraindications suggested. Thus, 
when a decision is made to not use blood salvage, it needs to be considered in light of the 
known risks associated with the alternative therapy, which is allogeneic blood (Waters, 
2013). 
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Table 2: General contraindications for intraoperative cell salvage (Table taken from 
Esper & Waters, 2011). 
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Blood Ordering Practice for Elective Surgeries 
When a patient is booked for a surgical procedure, it is often the surgeon’s office 
that is booking the procedure and ordering the blood products. A type and screen is 
typically ordered if transfusion is possible. This test verifies the blood type of the patient 
and screens the patient for any alloantibodies that might be present but does not set aside 
any blood units for the patients. Other times, a type and cross is ordered when transfusion 
seems highly likely or imminent. In this case, compatible RBCs are secured exclusively 
for a patient so they’ll be readily available when needed. 
The amount of blood ordered is usually based on routine practice or previous 
experiences of clinicians. Fear of not having sufficient blood available during surgery is 
common and leads to requests for larger amounts of blood products than necessary. As a 
result, without appropriate blood ordering guidelines, blood product waste easily 
becomes an issue (Khoshrang, Madani, Roshan, & Ramezanzadeh, 2013). Even when 
intraoperative blood salvage is used to reduce the amount of blood bank products 
required, unnecessary ordering of blood products is still a regular occurrence. Excessive 
ordering of blood products for a particular procedure is wasteful in many ways. Blood 
that can be used for other patients is set aside and reserved, thereby limiting the available 
inventory for other patients. If any particular bag of blood is set up for multiple patients 
before use, the time between irradiation and use will be increased, thus leading to a 
significant degradation in the quality of the RBCs. Furthermore, cells that are set up and 
then not used may expire, which will mean they will need to be disposed of as hazardous 
waste, adding to the operating expenses of the blood bank without any direct patient 
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benefit. Therefore, excessive ordering of blood can lead to outdating of blood, 
overburdening of blood bank personnel, depletion of blood bank resources, as well as 
wastage of time (Subramanian et al., 2010). 
In the past, efforts have been introduced to reduce unnecessary ordering of blood 
products. The maximum surgical blood ordering schedule (MSBOS) is one of the many 
examples. MSBOS aims to reduce the amount of blood crossmatched preoperatively for 
patients undergoing elective surgery (B. A. Friedman, Oberman, Chadwick, & Kingdon, 
1976). It is a list that comprises the maximum number of units of blood that should be 
crossmatched preoperatively for each commonly performed elective surgical procedure, 
and is established based on retrospective review of actual blood utilization pattern 
associated with each type surgical procedure at individual hospitals (Green, 1991). Past 
studies have shown that successful establishment and implementation of MSBOS can 
effectively lower crossmatch to transfusion ratio and reduce crossmatch charges (Lowery 
& Clark, 1989).  
 Although MSBOS has led to improvement in blood utilization, there are still 
certain drawbacks. The most significant one is the lack of accountability for individual 
differences, since the transfusion requirements between different patients undergoing the 
same surgery may not always be the same (Murphy et al., 1995).  In comparison, surgical 
blood order equation (SBOE) provide a way to calculate the number of units of blood that 
should be ordered while giving consideration to specific patient variables, such as pre- 
and postoperative hemoglobin (Hb) levels (Subramanian et al., 2010). SBOE was shown 
to be a highly accurate and cost-saving tool in predicting blood use in many types of 
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elective surgeries, including femoral fracture surgery (Kajja, Bimenya, Eindhoven, ten 
Duis, & Sibinga, 2011), spinal instrumentation and fusion surgery (Nuttall, Horlocker, et 
al., 2000), as well as total hip arthroplasty (Nuttall, Santrach, et al., 2000). A study 
carried out in 2001 also demonstrated that in comparison with MSBOS, SBOE can more 
effectively reduce crossmatch-to-transfusion ratio and improve efficiently of blood 
produce utilization (Sakurai & Okada, 2001). 
 
Standardized Clinical Assessment and Management Plan (SCAMP) 
SCAMPs are a novel quality improvement initiative that aim to standardize the 
assessment and management of a heterogeneous patient population who carry a 
predefined diagnosis (K. G. Friedman et al., 2010). The first SCAMP was conceived, 
designed, and implemented by physician and nursing leaders of the Cardiovascular 
Program at Boston Children’s Hospital (BCH) in 2009 (Rathod et al., 2010). Since then, 
more than 12,000 patients have been enrolled in forty-nine SCAMPs in nine states and 
Washington, D.C. (Farias et al., 2013). SCAMPs are essentially a practice tool for 
reducing practice variability while permitting flexibility, allowing providers to best 
exercise their clinical judgment and adapt treatment to individual patients (K. G. 
Friedman et al., 2010). Typically, a SCAMP is developed through retrospective analysis 
of current practice or review of medical literatures and relevant professional society 
standards, usually carried out by a multidisciplinary team of physicians and other 
healthcare providers, in order to establish a foundation for sound clinical practice 
(Fortescue, Lock, Galvin, & McElhinney, 2010). Once a SCAMP is developed initially, it 
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typically takes three to six months before it can be fully implemented. Analysis and 
modification of the SCAMP are continually conducted and made in order to rapidly 
optimize clinical decision-making and care delivery (Farias et al., 2013). 
In July 2012, a SCAMP relating to blood ordering practice was introduced at 
BCH in order to standardize blood ordering for orthopedic surgical procedures and 
reduce unnecessary utilization of blood products. This SCAMP involves an algorithm 
that is used as a reference when ordering blood products for orthopedic surgical patients 
scheduled for intraoperative cell salvage. Prior to the introduction of this SCAMP, blood 
ordering at BCH was largely based on personal preference and routine practice. 
Guidelines for blood ordering did exist, but were followed loosely at best. According to 
this SCAMP, if autologous blood was available and patients’ baseline hematocrit is 
greater than 35%, it is not necessary to order any additional blood products. If autologous 
blood was available and the baseline hematocrit was less than 35%, it is recommended 
that 1 unit of RBC should be ordered. In comparison, for those patients who do not have 
autologous blood readily available, it is suggested that 1 unit of RBC should be ordered 
for those with a baseline hematocrit greater than 35%, and 2 units of RBC should be 
ordered for those whose baseline hematocrit is less than 35%. Figure 4 demonstrates the 
SCAMP’s decision support tree for blood ordering (“SCAMPs Program: Blood 
Ordering/Cell Saver SDF 1,” 2012). 
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Figure 4. SCAMP Algorithm for Blood Ordering. (Figure taken from “SCAMPs 
Program: Blood Ordering/Cell Saver SDF 1,” 2012) 
 
 
 
Specific Aims 
Without specific blood ordering guidelines or algorithm, the amount of blood 
product requested and cross-matched is often much greater than the actual level of 
consumption. In a study published in 2013, Fernández et al. performed a retrospective 
chart review of intraoperative RBC transfusion for pediatric patients undergoing non-
cardiac surgery at a single institution. This analysis identified several procedures for 
which preoperative testing is performed and blood products are ordered, but which rarely, 
if ever, necessitate patient transfusion (Fernández, Cronin, Greenberg, & Heitmiller, 
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2013). Another study published in 2012 indicated that requests for blood often exceed its 
real use: of a total of 435 patients who underwent elective urological surgery at a single 
institution, cross-matching was performed for 97.5% of patients but only 8.5% required a 
blood transfusion in the operating room (Khoshrang et al., 2013). 
Efficient blood ordering guidelines have been developed in the past to provide a 
more accurate prediction of transfusion needs and to minimize waste. However, few 
studies in the past attempted to examine the blood ordering and utilization pattern with an 
emphasis on surgical cases that involve the use of intraoperative cell salvage. With the 
use of intraoperative cell-salvage devices, considerable change in the practice of ordering 
cross-matched blood should be made. The development of more efficient blood ordering 
guidelines, in conjunction with intraoperative cell-salvage, could promote maximum 
blood conservation and financial savings.   
The aim of this study is to examine the blood ordering and utilization pattern for 
orthopedic surgical cases at BCH, with an emphasis on patients who are scheduled for 
intraoperative cell salvage. We sought to compare the blood ordering and utilization 
pattern before and after the introduction of SCAMP, in July 2012, in order to assess its 
effectiveness in reducing excessive blood product ordering. This is in an effort to 
minimize blood product waste and unnecessary utilization of blood bank services while 
maximizing patient benefit. We hope the results of this study may be used to assess the 
progress of quality improvement of the blood product management process at BCH. This 
ultimate will allow us to revise current guidelines and develop new patient-specific, 
procedure-specific guidelines for preoperative blood product ordering and intraoperative 
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cell salvage scheduling. Additionally, the data from this study may reveal trends and 
areas where blood utilization practices can be improved. 
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METHODS 
 
 This is a retrospective study and chart review on all pediatric patients who were 
scheduled for orthopedic surgical procedures that have had blood products ordered and 
scheduled for intraoperative cell salvage at BCH from January 2011 to December 2013. 
Since SCAMP was introduced in July 2012, the blood ordering and utilization pattern 
before and after the introduction of SCAMP was compared, in order to assess SCAMP’s 
effectiveness in reducing excessive blood product ordering and increasing efficiency of 
blood utilization. Patients were grouped into one of two cohorts: those who had surgery 
scheduled during the 17 months before SCAMP was introduced, and those who had 
surgery during the 18 months after the introduction of SCAMP.  
 Retrospective analysis of two cohorts was performed through reviewing 
electronic medical records at BCH for relevant clinical and demographic information. 
These include intraoperative records, anesthesia records, operative notes, progress notes, 
laboratory results, as well as blood bank records. The following variables were collected: 
age, gender, weight, American Society of Anesthesiology (ASA) physical status, 
operative procedure, name of attending surgeon and anesthesiologist, estimated blood 
loss, availability and usage of autologous blood, units of allogeneic blood that were 
ordered, sent, transfused, and returned, volume of salvaged blood re-infused, hemostatic 
agent usage, the use of blood products including fresh frozen plasma (FFP), 
cryoprecipitate, as well as whole blood, pre and post-operative hemoglobin levels, and 
intraoperative use of crystalloid and colloid.  
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 The difference between blood units ordered and used, and the ratio of blood units 
transfused to units of blood ordered was calculated. These values were compared 
between two cohorts over time in order to assess whether there was a change in the 
effectiveness of blood ordering and utilization since the implementation of SCAMP. 
More specifically, efficiency of blood product utilization was evaluated using the 
difference between units of blood that are ordered and transfused. For each month, the 
difference (units ordered – units transfused) and the percentage utilization (units 
transfused ÷ units ordered) × 100% were calculated and recorded. Higher percentage 
utilization and a smaller difference between units ordered and units transfused was 
expected to be observed after the implementation of SCAMP, and would indicate better 
efficiency of blood utilization and measurable improvement. Similar calculations were 
done using the number of units of blood that is sent from the blood bank to the operative 
room instead of the number ordered. This is due to the fact that the number of units of 
blood ultimately sent to the operating room does not always equal the number of units 
initially ordered.   
 To evaluate the implementation of SCAMP over time, we also compared the 
number of blood units that should be ordered according to the SCAMP algorithm with 
what was actually ordered. A small difference between these two values would indicate 
good compliance with SCAMP protocol, while a larger difference would indicate that the 
SCAMP algorithm was poorly followed. In addition, we compared the difference 
between the number of blood units that should be ordered according to the SCAMP and 
the number of blood units that were actually transfused. This was done to assess whether 
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SCAMP provided an accurate prediction of the actual utilization of blood products during 
various elective surgical procedures included in this study. 
   
Statistical Analysis 
  Before the study, the projected sample size was estimated to be 900 procedures - 
500 for the 17 months pre-SCAMP and 400 post-SCAMP. It was assumed that this 
projected sample size would provide 80% statistical power to capture moderate effect 
sizes of 0.50 with respect to: 1) mean difference of 1 units of blood between what is 
ordered and transfused, assuming a standard deviation of 2 units and 2) a mean difference 
of 15% assuming a standard deviation of 30% in the percentage utilization ratio using 
paired t-tests. Patient characteristics were compared across cohorts using student’s paired 
t-test for continuous variables and Chi-square test for categorical variables. In addition, a 
longitudinal data analysis was applied using a time series autoregressive moving average 
(ARMA) model to evaluate whether the implementation of SCAMP has led to significant 
improvements in blood product utilization over time (Brockwell and Davis, 2002). 
Statistical analysis was performed using IBM SPSS Statistics (version 21.0, IBM, 
Armonk, NY) and Microsoft Excel 2012. Two-tailed values of P < 0.05 was considered 
statistically significant.  
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 RESULTS  
 
 From 1/1/2011 to 12/31/2013, 942 pediatric orthopedic surgical procedures were 
performed at BCH during which intraoperative cell salvaged was used. Data from July 
2012 to August 2012 could not be located, and therefore were not included in this study. 
Demographic data for all patients included are indicated in Table 3. Of the 942 patients, 
455 underwent operations before SCAMP was introduced, while 487 operations took 
place after the introduction of SCAMP. P values suggest that patient demographic across 
the two cohorts did not show any statistically significant differences.  
 
Table 3. Demographic Data. 
 PRE-SCAMP POST-SCAMP P value 
N 455 487  
Weight (kg) 53.4 ± 22.1 51.7 ± 22.3 0.245 
Age (Years) 14.7 ± 4.6 14.3 ± 5.2 0.228 
Male Gender (n, % of total)  162 (35.8%) 291 (37.4%) 0.609 
 
 
 In terms of clinical conditions of patients that are included in this study, the 
characteristics of patient populations in the two different cohorts were fairly similar with 
respect to ASA status, pre-operative hematocrit, as well as the amount of colloids given 
during surgery. Other variables listed, such as procedure type, estimated blood loss, pre-
donated autologous blood availability, volume of salvaged blood that was transfused, 
volume of crystalloid used, and TXA usage, were significantly different between the two 
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cohorts. Table 4 demonstrates the differences in patient characteristics between the pre-
SCAMP and post-SCAMP groups. 
 
Table 4. Patient Characteristics: Clinical Condition. 
 PRE-SCAMP POST-SCAMP P value 
ASA Status (%)     
1 18.5 15.6 0.672 
2 50.3 51.2 0.672 
3 29.5 31.3 0.672 
4 1.8 1.6 0.672 
Procedure Type (%)    
Spine  58.9 63.0 0.006 
Hip  29.0 27.9 0.006 
Femur  9.5 4.3 0.006 
Hip & Femur  2.2 4.7 0.006 
Spine & Hip  0.2 0 (0.0%) 0.006 
Spine & Femur  0.2 0 (0.0%) 0.006 
EBL (ml) 841.6 ± 648.5 687.9 ± 688.8 <0.001 
EBL (ml/kg) 18.1 ± 17.4 14.2 ± 15.8 0.002 
EBL (% of EBV) 25.9 ± 24.8 20.2 ± 22.6 0.002 
Autologous Blood Availability (%) 18 12.90 0.031 
Cell Saver Auto-reinfusion (ml) 224.7 ± 221.9 174.3 ± 184.8 <0.001 
Cell Saver Auto-reinfusion (ml/kg) 4.4 ± 5.2 3.4 ± 3.7 0.001 
Pre-op Hematocrit  39.2 ± 3.9 39.1 ± 3.6 0.558 
TXA use (%) 29.4 37.0 0.013 
Crystalloid Use (ml) 2880.6 ± 1359.9 2485.8 ± 1187.5 <0.001 
Colloid Use (ml) 321.1 ± 458.3 296.7 + 416.6 0.387 
 
 
 According to Table 5, our data indicated that since the introduction of SCAMP in 
July 2012, there has been a mean difference of 0.5 units of blood between what was 
ordered and transfused, from a value of 1.4 before the introduction of SCAMP to that of 
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0.9 afterwards. Additionally, the mean percentage utilization of blood products increased 
from 29.2% to 53.6% since the introduction of SCAMP, demonstrating an increase of 
24.4%. Similar calculations that were done using the number of blood units that were sent 
to the operating room instead of ordered also indicated an improvement in blood 
utilization, with a mean reduction of a difference of 0.5 units of blood between what was 
sent and what was transfused, with a mean percentage utilization increase of 25.3%. The 
extremely small P values indicated these reductions in the difference between units of 
blood that were ordered/sent and transfused, as well as the increases in percentage 
utilization, are highly statistically significant. In addition, the percentage utilization of 
blood products and the difference between units of blood that were ordered or sent and 
transfused were also evaluated on a monthly basis. These trends are demonstrated in 
Figure 5 – 9. 
 
Table 5: Blood Utilization Pattern 
 PRE-SCAMP POST-SCAMP P value 
|Ordered – Used| 1.4  ±  0.9 0.9  ±  1.0 <0.001 
|Sent – Used| 1.1  ±  0.9 0.6 ± 0.8 <0.001 
Used/Ordered x 100% 29.2 ± 45.8 53.6 ± 57.8 <0.001 
Sent/Ordered x 100% 40.6 ± 45.1 65.9 ± 45 <0.001 
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Figure 5. Comparison of Ordered and Used Blood Products. Differences between 
blood units that were ordered and used before and after the introduction of SCAMP in 
July 2012 were calculated. 
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Figure 6. Comparison of Sent and Used Blood Products. Differences between blood 
units that were sent to the operative room and used before and after the introduction of 
SCAMP in July 2012 were calculated. 
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Figure 7. Percentage Utilization of Blood Products Over Time. Before and after the 
introduction of SCAMP in July 2012, percentage utilization of blood products were 
calculated using number of units of blood ordered as the denominator.  
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Figure 8. Percentage Utilization of Blood Products Over Time. Before and after the 
introduction of SCAMP in July 2012, percentage utilization of blood products were 
calculated using number of units of blood sent as the denominator. 
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Figure 9: Comparison of Percentage Utilization Over Time. Percentage utilization 
values calculated using units of blood products ordered and sent respectively as the 
denominator were compared on a monthly basis over time. 
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Figure 10. SCAMP Implementation. The difference between number of blood units 
recommended and number of blood units ordered demonstrates the difference between 
SCAMP recommended usage and actual usage of blood products. 
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 To evaluate the implementation of this SCAMP, the difference between the 
number of units of blood that should be ordered according to SCAMP calculation and 
number of units of blood that were actually ordered were calculated. This value was not 
statistically significant between the pre and post SCAMP group (p > 0.05). Table 6 shows 
an average of 0.85 unit of difference after the introduction of SCAMP. This value was 
also evaluated over time on a monthly basis. The resulting trend is shown in Figure 10. 
 
 
Table 6. SCAMP Implementation and Accuracy.  
 
 PRE-SCAMP POST-SCAMP P value 
|Recommended – Ordered| 0.86 ± 0.87 0.85 ± 0.73 0.858 
|Recommended – Used| 0.89 ± 0.75 0.99 ± 0.61 0.028 
 
 
 Additionally, to assess the accuracy of SCAMP in predicting actual blood product 
usage, we calculated the difference between the SCAMP recommended usage and actual 
usage of blood products, and compared this value between the pre-SCAMP and post-
SCAMP group. Table 6 shows the results.  
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DISCUSSION 
 
 This retrospective analysis identified that in general, the introduction of SCAMP 
at BCH in July 2012 led to a statistically significant improvement in the efficiency of 
blood product utilization. Percentage utilization was markedly improved, and the number 
of units of blood that were ordered better matched actual consumption after the 
introduction of SCAMP. Since the number of units of blood ordered does not always 
equal the number of units that of sent to the operating room, we felt that the difference 
between the number of units of blood sent to the operating room and those used would 
better reflect the actual utilization and wastage of blood products. Consequently, | units 
sent – units used | and percentage utilization calculated this way also demonstrated 
significant improvement in the efficiency of blood production utilization. Analysis of 
blood utilization patterns on a monthly basis also indicated a similar result. After 
introduction of SCAMP, data showed that blood utilization was improved overall. 
However, when analyzed on a monthly basis, our data did not reveal an upward trend in 
percentage utilization or a downward trend in blood wastage after the introduction of 
SCAMP. 
 Efficient blood ordering guidelines have been developed in the past and led to a 
more accurate prediction of the need for intraoperative blood transfusion and improved 
blood utilization in many cases. In a study published in 2003, a patient-specific blood 
ordering system, which included patient and surgeon variables in transfusion prediction, 
was developed and was proven to be more accurate than the commonly used MSBOS 
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(Palmer, Wahr, O’Reilly, & Greenfield, 2003). Additionally, Frank et al. at the John 
Hopkins Medical Institution used blood utilization data extracted from an anesthesia 
information management system to create an institution-specific blood ordering 
algorithm. This algorithm helped eliminate unnecessary blood orders and led to a 
calculated potential reduction in their hospital charge of $211,448 per year (Frank et al., 
2013).  
 Interestingly, when examining the actual implementation of SCAMP since its 
introduction, data revealed that SCAMP did not become better implemented over time. 
The mean difference between the units recommended and units ordered did not decrease 
over time. Data also suggested that in terms of the difference between units 
recommended and units ordered, there is no statistical difference between the pre-
SCAMP and post-SCAMP group. This may be explained by the fact that although the 
absolute difference between the number of units recommended and units ordered were 
similar between the pre-SCAMP and post-SCAMP, the pre-SCAMP group mostly 
represented “over-ordering” scenarios, whereas the post-SCAMP group represented 
“under-ordering” scenarios. Prior to the introduction of SCAMP, the amount of blood 
ordered usually exceeded SCAMP recommendation, since over ordering was common 
practice. In comparison, after the introduction of SCAMP, less blood products were 
ordered in general, and in many cases, the amount of blood ordered was less than what 
was recommended by SCAMP but was still sufficient. As a result, both “over-ordering” 
and “under-ordering” lead to the similar absolute difference between the number of units 
recommended and units ordered. 
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 Additionally, upon examining SCAMP’s decision support tree for blood ordering, 
one would notice that in order to have 0 units of blood ordered, a patient must have 
autologous blood available and have a pre-operative hematocrit value that is greater than 
35. Among the study population, less than 20% of the patients have pre-donated 
autologous blood readily available. This means that if SCAMP was to be followed 
strictly, the majority of the patients would need to have at least 1 units of RBC ordered. 
With the use of intraoperative cell salvage especially, many patients did not require any 
blood transfusion at all. Data from this study also indicated a mean difference of 0.99 
units of blood between the number of units recommended by SCAMP and the number of 
units transfused, with a standard deviation of 0.61, after the implementation of SCAMP. 
Without other studies to compare to as references, it is difficult to conclude whether this 
difference indicated poor or satisfactory prediction of actual utilization of blood products.  
 Furthermore, the existing SCAMP algorithm did not take into consideration the 
number of units of pre-donated autologous blood that are available. Its decision support 
tree separates patients into categories based on the availability of autologous blood 
without further differentiation. In other words, a patient who has multiple units of 
autologous blood available should obviously have less blood ordered than someone who 
only has 1 unit. Therefore, further study should be carried out in order to provide better 
knowledge of the actual level of utilization of blood products, as well as other parameters 
that may affect blood product ordering and utilization. In terms of data analysis, future 
studies should also investigate both incidences of over-ordering as well as under-ordering 
of blood products, in order to gain a more complete understanding of actual utilization 
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pattern. Appropriate modifications of the current SCAMP protocol should be made base 
on these knowledge, so that blood products orders can more accurately reflect actual 
transfusion needs.  
 Because this is a retrospective study, some of the electronic medical record were 
entered incorrectly and therefore omitted. Data from the first two months after the 
implementation of SCAMP were also missing. Additionally, we examined a 34-month 
period only. A longer study period with a larger study population may reveal numbers 
and trends that may be different from the results of this study. Finally, it was difficult to 
determine the person responsible for ordering the blood products. Knowledge of the 
ordering provider may provide valuable insights into blood ordering practice, since the 
level of past experience of the provider may influence the amount of blood ordered.  
 In conclusion, the introduction of SCAMP in July 2012 at BCH did improve 
blood product utilization and reduce unnecessary blood product ordering. However, 
further studies should be conducted to provide knowledge that can be used to modify the 
existing SCAMP to better predict actual transfusion needs.   
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